The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study.

By David W. Dunstan, P. Zimmet, T. Welborn, M. D. de Courten, A. Cameron, R. Sicree, T. Dwyer, S. Colagiuri, D. Jolley, M. Knuiman and 2 more. Diabetes Care, 2002

1,006 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Physiology

View Paper: https://www.semanticscholar.org/paper/6bc983c34702c9beffbfa291b1f0996e22b392aa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. P. Zimmet
2. J. Shaw
3. David W. Dunstan
4. A. Cameron
5. V. Basevi
6. W. Westcott

In Epidemiology

1. P. Zimmet
2. J. Shaw

In Physiology

1. N. Owen
2. G. Healy
3. David W. Dunstan
4. P. Zimmet
5. J. Shaw
6. Ester Cerin
7. W. Westcott
8. V. Basevi

Citations in the corpus

• Breaks in Sedentary Time (2008, methodology): “Demographic and behavioral attributes were assessed using questionnaires administered by trained interviewers using standard protocols described in earlier papers (19,21).”
• Diabetes, depression, and quality of life: a population study. (2004, background): “This is even more important given that diabetes is increasing in Australia and in many other industrialized countries (14).”
• High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. (2002, background): “Given that the prevalence of type 2 diabetes increases with age (9) and that aging is associated with a reduction in muscle strength and metabolic control, both of which are influenced by the progressive age-related decline in muscle mass (sarcopenia) (10), resistance training may represent an effec”
• Protein tyrosine phosphatase 1B inhibitors for diabetes (2002, neutral): “ACO, acyl-coenzyme-A oxidase; CPT1, carnitine palmitoyl transferase; CREB, cyclic-AMP-response-element binding protein; forkhead TF, forkhead transcription factor; I, insulin; IR, insulin receptor; PtdIns(3,4,5)P3, phosphatidylinositol-3,4,5-trisphosphate.”
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. (2004, neutral): “Australia, 2000 (21)† 11,247 25 New Zealand”
• Overweight and obesity in Australia: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab) (2003, background): “The consequences of high rates of overweight and obesity are likely to be profound, with the AusDiab data also showing that Australia now has one of the highest rates of type 2 diabetes in the developed world.(4) The high prevalence of obesity found is still considerably lower than the reported rate”
• Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. (2003, background): “It is reasonable to anticipate that this problem will worsen in the midst of the epidemic of obesity and diabetes in the United States [4] and elsewhere [5], an epidemic that disproportionately affects Hispanic and non-Hispanic black persons [6].”
• Breaking Up Prolonged Sitting Reduces Postprandial Glucose and Insulin Responses (2012, background): “25 kg/m(2) (overweight or obese), representing a population with a heightened diabetes risk (27).”